Benzinga | Jan 4, 2021 11:13AM EST

Evercore ISI Group Downgrades Twist Bioscience to In-Line, Raises Price Target to $140

Evercore ISI Group analyst Vijay Kumar downgrades Twist Bioscience (NASDAQ:TWST) from Outperform to In-Line and raises the price target from $125 to $140.